The prevailing view of research science is that professors and laboratory staff work on obscure challenges for which a lifetime might not be enough time to solve. Or that their projects might have limited application in the ‘real’ world. If that’s how you think, you haven’t met Dr. Barry Karger.
Northeastern University researchers have extensively profiled the proteins of rare cells in blood, a feat that was previously impossible. By successfully isolating and characterizing rare cells that make up just 0.001 percent or less of the total cells present in blood, faculty members have built a foundation for proteomics-based personalized medicine.
Northeastern professor Barry Karger, whose contributions to analytical chemistry helped enable the sequencing of the human genome, received the Arnold O. Beckman Medal and Award for Outstanding Scientific Achievements in the field of electrodriven separation techniques.
He has helped guide close to 200 students, postdoctoral researchers, and staff members, and now Dr. Barry Karger has been named to The Analytical Scientist’s POWER LIST.
Northeastern University’s Barnett Institute of Chemical and Biological Analysis formally announced a technology alliance partnership with Thermo Fisher Scientific, a multibillion-dollar analytical instrumentation and product company, based in San Jose, Calif., with corporate offices in Waltham, MA.